ISSUER PROFILE · CIK 0000034956 · CUSIP 88032L605
Tenax Therapeutics, Inc.TENX
15 13D/G filings
11 distinct filers
6 insider transactions (365d)
Cross-Reference Snapshot
Activist filings
15
6 SCHEDULE 13G · 1 SCHEDULE 13D/A · 8 SC
Distinct filers
11
multi-activist cluster
Insiders (365d)
6
4 buys · 0 sales
Latest short DTC
3.22
as of 2026-10-15
Institutional Consensus · 2025-12-31
Held by elite portfolio managers
1 holder · $5.16M
Point72 Asset Mgmt
13D/G Filings Timeline · 15 total
Form 4 Insider Transactions · last 365d
| Date | Insider | Role | Type | Shares | Price | Value |
|---|
| 2026-09-16 |
Doogan Declan |
director |
Buy |
53,000 |
$1.92 |
$102K |
| 2026-09-15 |
Giordano Christopher Thomas |
director, officer |
Buy |
4,850 |
$1.82 |
$9K |
| 2026-09-11 |
Giordano Christopher Thomas |
director, officer |
Buy |
6,000 |
$1.88 |
$11K |
| 2026-09-11 |
STAAB THOMAS R II |
officer |
Buy |
5,675 |
$1.94 |
$11K |
| 2026-07-13 |
Giordano Christopher Thomas |
director, officer |
Option exercise |
219 |
$3.55 |
$777 |
| 2026-07-13 |
Giordano Christopher Thomas |
director, officer |
Option exercise |
8,500 |
$5.94 |
$50K |
FINRA Short Interest History
| Settlement | Short Interest | Days to Cover | % Δ vs prior |
|---|
| 2026-10-15 |
7,229,252 |
3.22 |
+0.7% |
| 2026-09-30 |
7,182,126 |
2.35 |
+30.5% |
| 2026-09-15 |
5,503,842 |
1.03 |
-40.7% |
| 2026-08-31 |
9,276,905 |
1.12 |
+69.5% |
| 2026-08-14 |
5,473,983 |
1.00 |
+114.1% |
| 2026-07-31 |
2,556,478 |
1.86 |
+24.9% |
| 2026-07-15 |
2,046,537 |
1.37 |
+14.5% |
| 2026-06-30 |
1,787,937 |
1.19 |
+132.9% |
| 2026-06-15 |
767,532 |
1.00 |
-3.1% |
| 2026-05-29 |
792,041 |
1.79 |
+2.1% |
| 2026-05-15 |
775,851 |
1.12 |
+6.2% |
| 2026-04-30 |
730,696 |
1.14 |
+275.8% |
Alert me when any activist files on Tenax Therapeutics, Inc.
Free. We email you when criteria match. One-click unsubscribe in every email.
Track every activist who touches this name.
Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.
See pricing →